CDEK
← All trials

NCT03103919

Phase 4Interventional

Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.

View on ClinicalTrials.gov ↗

Timeline

Start date
Mar 16, 2017
Primary completion
Jan 2, 2018
Completion date
Jan 2, 2018
First posted
Apr 6, 2017
Last posted
Feb 19, 2019
Enrollment
40
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

  • UCBLead sponsor
  • UCBStudy director

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.